Long-term efficacy and safety of lomitapide in patients with familial chylomicronemia syndrome (FCS): Data from the LOCHNES study

Autor: Giammanco, A., Cefalù, A., D'Erasmo, L., Iannuzzo, G., Noto, D., Montali, A., Zambon, A., Forte, F., Suppressa, P., Giannini, S., Barbagallo, C.M., Ganci, A., Nardi, E., Brancatelli, G., Caldarella, R., Ciaccio, M., Arca, M., Averna, M.
Zdroj: In Atherosclerosis August 2023 379 Supplement 1:S5-S5
Databáze: ScienceDirect